
|Articles|April 1, 2003
'Pan' Handles Photoaging
San Francisco -- Alitretinoin 0.1 percent gel (Panretin) appears to be an effective modality for improving the appearance of photoaged skin and may have an added benefit for treating some benign and precancerous lesions common in aging skin, according to preliminary results of a pilot trial conducted by investigators from the Cosmetic Center of the University of Miami.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
3
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
4
Introducing Dermatology Times NP/PA Connect
5











